Holen Sie sich die Stockscreener-App
1.31
0.00%
0.01
Schlusskurs vom Vortag:
$1.30
Offen:
$1.27
24-Stunden-Volumen:
4,396
Relative Volume:
0.00
Marktkapitalisierung:
$1.18M
Einnahmen:
$8.17M
Nettoeinkommen (Verlust:
$-16.57M
KGV:
-0.0165
EPS:
-79.4169
Netto-Cashflow:
$-9.41M
1W Leistung:
-16.67%
1M Leistung:
-41.18%
6M Leistung:
-69.12%
1J Leistung:
+7.44%
1-Tages-Spanne:
$1.27
$1.31
1-Wochen-Bereich:
$1.195
$1.6575
52-Wochen-Spanne:
$0.19
$25.95
Nuwellis Inc Stock (NUWE) Company Profile
Firmenname
Nuwellis Inc
Sektor
Branche
Telefon
952-345-4200
Adresse
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
1.31 | 1.16M | 8.17M | -16.57M | -9.41M | -79.42 |
|
ABT
Abbott Laboratories
|
110.10 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
356.68 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.82 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.73 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.36 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | ROTH MKM | Buy |
Nuwellis Inc Aktie (NUWE) Neueste Nachrichten
Nuwellis Earnings Call: Margin Gains Amid Cash Strain - TipRanks
Nuwellis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Nuwellis (NUWE) Q4 2025 Earnings Call Transcript - The Globe and Mail
Nuwellis (NUWE) Reports Increased Q4 Revenue Amidst Strategic Re - GuruFocus
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results - Bitget
Nuwellis Q4 2025 Earnings Call Transcript - MarketBeat
Nuwellis Earnings Preview - Benzinga
Nuwellis Inc expected to post a loss of $1.56 a shareEarnings Preview - TradingView
Nuwellis appoints Stuart Goldstein as clinical strategy director By Investing.com - Investing.com Australia
Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy - Bitget
Nuwellis appoints Stuart Goldstein as clinical strategy director - Investing.com
NUWEForm PRE 14AOther preliminary proxy statements - ADVFN Ltd
Nuwellis (NUWE) director David McDonald reports nonstatutory option holdings - Stock Titan
NUWE SEC FilingsNuwellis Inc 10-K, 10-Q, 8-K Forms - Stock Titan
NUWE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
NUWE Technical Analysis & Stock Price Forecast - Intellectia AI
Nuwellis Expands Board With New Independent Financial Experts - TipRanks
Nuwellis adds two directors with medical device experience - Investing.com
Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors - The Manila Times
Two medtech leaders join Nuwellis board with capital markets experience - Stock Titan
Aug Fed Impact: What is Nuwellis Incs 5 year growth outlookGDP Growth & Low Risk High Win Rate Picks - baoquankhu1.vn
What’s the MACD signal for Nuwellis Inc.Portfolio Performance Summary & Free Verified High Yield Trade Plans - mfd.ru
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026 - Bitget
Nuwellis sets March 10 call to unpack Q4 and 2025 financial results - Stock Titan
Returns Recap: What is the cash position of WSOBWatch List & Low Risk High Reward Ideas - baoquankhu1.vn
What is the earnings history of Nuwellis Inc.2025 Pullback Review & Weekly Return Optimization Alerts - mfd.ru
Does Nuwellis Inc. have pricing powerJuly 2025 Momentum & Free Technical Pattern Based Buy Signals - mfd.ru
Nuwellis Shares Drop as Company Halts REVERSE-HF Clinical Trial - MSN
Portfolio Shifts: Will Nuwellis Inc benefit from seasonalityLayoff News & Safe Capital Investment Plans - baoquankhu1.vn
Performance Recap: Is Silvercorp Metals Inc subject to activist investor interest2025 Key Lessons & Community Verified Swing Trade Signals - baoquankhu1.vn
Recap Report: What is Ellington Financial Incs revenue forecastMarket Trend Report & Weekly Return Optimization Alerts - baoquankhu1.vn
What is Nuwellis Inc. s 5 year growth outlookWeekly Profit Recap & Daily Profit Maximizing Tips - mfd.ru
Nuwellis appoints CFO - MSN
Is Nuwellis Inc. forming bullish engulfing patternsJuly 2025 Earnings & Free Community Supported Trade Ideas - mfd.ru
Can Nuwellis Inc. stock double in the next yearQuarterly Investment Review & AI Based Buy and Sell Signals - mfd.ru
NUWE PE Ratio & Valuation, Is NUWE Overvalued - Intellectia AI
NUWE Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
NUWE Earnings{quarter} AI PredictionIntellectia AI™ - Intellectia AI
Nuwellis to acquire Rendiatech, raises $5 mln in private placement - MSN
How Nuwellis Inc. stock performs in weak economy2025 Historical Comparison & Weekly Stock Performance Updates - mfd.ru
What momentum indicators show for Nuwellis Inc. stockRate Cut & Verified Stock Trade Ideas - mfd.ru
Is Nuwellis Inc. stock positioned for digital transformationMarket Sentiment Review & Proven Capital Preservation Tips - mfd.ru
Veru (VERU) Q1 2026 Earnings Call Transcript - AOL.com
Nuwellis (NUWE) director Katharyn Field reports no beneficial share ownership on Form 3 - Stock Titan
Risk Recap: Is OTLY stock overvalued or fairly priced2025 Key Highlights & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Will Nuwellis Inc. stock gain from lower inflationQuarterly Investment Review & Verified Technical Trade Signals - mfd.ru
Recession-proof Dividend King offers safe 2.2% yield - AOL.com
Nuwellis announces $5M private placement, warrant inducement transaction - TipRanks
Market Recap: Can Nuwellis Inc stock double in the next yearDay Trade & Daily Momentum Trading Reports - baoquankhu1.vn
Maxim Group Maintains Nuwellis(NUWE.US) With Hold Rating, Raises Target Price to $5.5 - 富途牛牛
Nuwellis stock falls after CFO appointment announcement - Investing.com Australia
Finanzdaten der Nuwellis Inc-Aktie (NUWE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):